FOXP1 antibodies are pivotal in studying transcriptional regulation, immune cell development, and cancer biology.
B Cells: FOXP1 regulates mature B cell survival and antibody production. Its deletion impairs B-1 B cell differentiation and reduces T-independent immune responses .
T Cells: FOXP1 suppresses follicular helper T (Tfh) cell differentiation by inhibiting IL-21 and ICOS signaling .
B-Cell Lymphomas: High FOXP1 expression correlates with poor prognosis in diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma .
Angiogenesis: FOXP1 promotes endothelial cell proliferation and tube formation, suggesting a role in tumor vasculature development .
FOXP1 antibodies have been used to study:
Direct transcriptional repression of plasma cell differentiation genes (PRDM1, IRF4, XBP1) .
Epigenetic regulation of MHC class II genes (HLA-DRA, CD74) in DLBCL .
Mature B Cells: FOXP1 deletion reduces Bcl-xl expression, leading to increased apoptosis and impaired T-independent immune responses .
Plasma Cells: FOXP1 overexpression blocks plasma cell differentiation by repressing PRDM1 and XBP1 .
DLBCL: High FOXP1 expression inhibits MHC class II antigen presentation, impairing immune surveillance .
Angiogenesis: FOXP1 knockdown reduces endothelial cell migration and tube formation, highlighting its role in tumor angiogenesis .
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000–1:2000 |
| Immunohistochemistry | 1:50–1:100 |
| Flow Cytometry | 1:50 |
| ChIP/ChIP-seq | 1:100 |
| Pathway | Target Genes | Effect |
|---|---|---|
| Tfh Cell Differentiation | IL-21, ICOS | Negative regulation |
| Plasma Cell Differentiation | PRDM1, IRF4, XBP1 | Repression |
| MHC Class II Expression | HLA-DRA, CD74 | Inhibition |
FOXP1 is a transcriptional repressor. Its expression is prominent in various regions of the developing central nervous system, particularly the midbrain-hindbrain boundary, hindbrain, and spinal cord. PMID: 17876603